Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bd042bcccbc1daa26d3556ba65b6c67e |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4178 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-417 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-417 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 |
filingDate |
2013-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9859604697ee69d2b82c6b7e73274bc6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_580ee461628732a43d6023e53b665cfa |
publicationDate |
2015-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
IN-2015DN04089-A |
abstract |
The present invention relates to compounds of formula I: for use in treating pulmonary arterial hypertension and associated conditions where R1 R2 and R3 are the same or different and signify hydrogens halogens alkyl alkylaryl alkyloxy hydroxy nitro amino alkylcarbonylamino alkylamino or dialkylamino group; R4 signifies hydrogen alkyl alkylaryl or alkylheteroaryl; X signifies CH2 oxygen atom or sulphur atom; n is 1 2 or 3 with the proviso that when n is 1 X is not CH2; and the individual (R) and (S) enantiomers or mixtures of enantiomers and pharmaceutically acceptable salts thereof. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021005623-A1 |
priorityDate |
2012-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |